Versant Capital Management, Inc Biolife Solutions Inc Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,310 shares of BLFS stock, worth $29,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,310
Previous 140
835.71%
Holding current value
$29,160
Previous $3,000
833.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BLFS
# of Institutions
201Shares Held
48.7MCall Options Held
2.5KPut Options Held
182K-
Casdin Capital, LLC New York, NY8.71MShares$194 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$122 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$79 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$62.4 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$34.1 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $950M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...